Hydromorphone Hydrochloride 00641-6254-01
- Manufacturer
- Hikma Pharmaceuticals Usa Inc.
- Dosage Form
- Injection, Solution
- Route
- Intramuscular, Intravenous, And Subcutaneous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- May 13, 2025
- Listing Expires
- December 31, 2026
- Application
- NDA217812
Active Ingredients
| Ingredient | Strength |
|---|---|
| Hydromorphone Hydrochloride | 2 mg/mL |
Drug Class
Full Opioid Agonists [MoA]Opioid Agonist [EPC]
Selected Package
00641-6254-01Selected1 VIAL in 1 CARTON (0641-6254-01) / 20 mL in 1 VIAL